TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||
Earning before tax | -99.13%590.87K | -19.50%133.72M | -24.84%68.13M | -11.92%166.1M | 19.13%90.65M | --188.57M | --76.09M |
Profit adjustment | |||||||
Interest expense - adjustment | -77.91%1.75M | 179.77%10.83M | 2,058.53%7.91M | -241.61%-13.58M | -63.17%366.53K | ---3.97M | --995.14K |
Investment loss (gain) | -26,981.51%-1.06M | 15.24%-3.48M | -95.96%3.95K | -248.35%-4.11M | 103.44%97.79K | --2.77M | ---2.85M |
Impairment and provisions: | 34.23%-107.14K | -102.12%-177.01K | -101.10%-162.89K | 1,172.13%8.35M | 2,843.07%14.84M | --656.35K | --504.2K |
-Other impairments and provisions | 34.23%-107.14K | -102.12%-177.01K | -101.10%-162.89K | 1,172.13%8.35M | 2,843.07%14.84M | --656.35K | --504.2K |
Revaluation surplus: | -155.32%-91.83M | -222.37%-146.63M | ---35.97M | --119.83M | ---- | ---- | ---- |
Asset sale loss (gain): | 151.39%118.09K | -788.44%-221.32K | -614.79%-229.79K | --32.15K | -2,143.59%-32.15K | ---- | --1.57K |
-Loss (gain) on sale of property, machinery and equipment | 151.39%118.09K | -788.44%-221.32K | -614.79%-229.79K | --32.15K | -2,143.59%-32.15K | ---- | --1.57K |
Depreciation and amortization: | 5.23%13.99M | 20.57%27.48M | 19.09%13.3M | 29.10%22.79M | 27.41%11.17M | --17.66M | --8.76M |
-Amortization of intangible assets | 65.72%1.16M | 14.34%1.56M | 0.10%699.69K | -10.14%1.37M | -3.21%698.97K | --1.52M | --722.11K |
-Other depreciation and amortization | -15.56%716.39K | 20.66%1.73M | 13.19%848.37K | -11.42%1.43M | 17.45%749.53K | --1.62M | --638.14K |
Exchange Loss (gain) | -77.04%109.46K | -79.96%262.98K | 7,918.16%476.75K | 741.41%1.31M | -5.10%-6.1K | --155.97K | ---5.8K |
Change of operating capital | |||||||
Inventory (increase) decrease | -297.32%-56.62M | 219.63%39.4M | 123.17%28.69M | ---32.94M | -52.43%-123.84M | ---- | ---81.24M |
Accounts receivable (increase)decrease | -109.76%-1.71B | 152.44%1.05B | 76.06%-816.57M | 24.44%-2B | -44.39%-3.41B | ---2.64B | ---2.36B |
Accounts payable increase (decrease) | 260.97%3.65B | -77.67%1.71B | -89.85%1.01B | 3.43%7.65B | 158.39%9.96B | --7.39B | --3.85B |
Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | 288.95%376.43M | ---- | ---199.22M |
Special items of business | -112.09%-3.97M | 237.21%38.05M | -51.91%32.81M | -228.71%-27.73M | -78.17%68.22M | --21.55M | --312.58M |
Adjustment items of business operations | 552.77%1.8B | -52.42%2.82B | -96.01%275.92M | 19.40%5.92B | 434.35%6.92B | --4.96B | --1.29B |
Net cash from operations | 482.12%1.8B | -51.55%2.85B | -95.58%308.72M | 18.33%5.89B | 334.65%6.98B | --4.98B | --1.61B |
Cash flow from investment activities | |||||||
Dividend received - investment | 20.97%269.51K | ---- | 179.69%222.78K | 24.26%9.54M | -42.73%79.65K | --7.68M | --139.08K |
Sale of fixed assets | -87.99%29.72K | 605.73%258.12K | 145.60%247.46K | -96.25%36.57K | 8,388.84%100.76K | --976.19K | --1.19K |
Purchase of fixed assets | -1,388.32%-16.94M | -58.73%-21.57M | -42.15%-1.14M | 22.54%-13.59M | 27.26%-800.87K | ---17.54M | ---1.1M |
Recovery of cash from investments | ---- | ---- | --5M | ---- | ---- | --297.5M | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---585M | ---8.21M |
Net cash from investment operations | -484.24%-16.64M | -431.86%-21.31M | 798.16%4.33M | 98.65%-4.01M | 93.24%-620.46K | ---296.38M | ---9.17M |
Net cash before financing | 468.75%1.78B | -51.87%2.83B | -95.52%313.05M | 25.73%5.88B | 337.10%6.98B | --4.68B | --1.6B |
Cash flow from financing activities | |||||||
New borrowing | 27.99%60M | -60.76%88.29M | -78.20%46.88M | --225M | --215M | ---- | ---- |
Refund | -407.00%-50.7M | -1,245.16%-281.87M | ---10M | ---20.95M | ---- | ---- | ---27.87M |
Dividends paid - financing | 95.85%-515.34K | -59.32%-28.73M | ---12.4M | 23.73%-18.03M | ---- | ---23.64M | ---- |
Other items of the financing business | -1,342.88%-14.99M | -18.54%-17.8M | -183.41%-1.04M | -55.64%-15.02M | ---366.53K | ---9.65M | ---- |
Net cash from financing operations | -126.47%-6.2M | -240.42%-240.12M | -89.08%23.44M | 613.58%170.99M | 870.14%214.63M | ---33.29M | ---27.87M |
Effect of rate | -85.23%4.52K | 459.40%143.43K | 12.94%30.62K | 116.44%25.64K | 102.63%27.11K | ---155.97K | ---1.03M |
Net Cash | 427.29%1.77B | -57.20%2.59B | -95.33%336.49M | 30.31%6.06B | 358.54%7.2B | --4.65B | --1.57B |
Begining period cash | 16.37%18.42B | 61.95%15.83B | 61.95%15.83B | 90.61%9.78B | 90.61%9.78B | --5.13B | --5.13B |
Cash at the end | 24.93%20.2B | 16.37%18.42B | -4.75%16.17B | 61.95%15.83B | 153.44%16.97B | --9.78B | --6.7B |
Cash balance analysis | |||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.